Q15413 (RYR3_HUMAN) Homo sapiens (Human)
Ryanodine receptor 3 UniProtKBInterProSTRINGInteractive Modelling
Available Structures
5 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of Human RYR Receptor 3 (848-1055) | monomer | 9×GOL; | ||||
| Assess | ||||||
| Closed-form Crystal Structure of Human RYR Receptor 3 ( 848-1055) | monomer | |||||
| Assess | ||||||
| Open-form Crystal Structure of Human RYR Receptor 3 ( 848-1055) | monomer | |||||
| Assess | ||||||
| Crystal Structure of Human RYR Receptor 3 ( 848-1055) in Complex with ATP | monomer | 1×ATP; 2×GOL; 1×TRS; | ||||
| Assess | ||||||
| Crystal structure of human ryanodine receptor 3 (2597-2800) | monomer | 3×SO4; 3×GOL; | ||||
| Assess | ||||||
14 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8vjk.1.A | monomer | 0.72 | 1×ZN; 1×CFF; 2×ATP; 1×CA; | 67.45 | ||
| Assess | ||||||
| 7tzc.1.I | monomer | 0.71 | 1×ATP; 1×ZN; 1×CFF; | 67.53 | ||
| Assess | ||||||
| 8uq2.1.A | monomer | 0.69 | 1×ZN; 1×ATP; | 69.55 | ||
| Assess | ||||||
| 8dve.1.J | monomer | 0.64 | 1×CFF; 1×CA; 1×ATP; 1×ZN; | 67.53 | ||
| Assess | ||||||
| 6x32.1.B | monomer | 0.58 | 1×ZN; | 66.13 | ||
| Assess | ||||||
| 6x33.1.B | monomer | 0.56 | 1×ZN; | 66.20 | ||
| Assess | ||||||
| 4uwa.1.A | homo-4-mer | 0.56 | 61.48 | |||
| Assess | ||||||
| 3j8h.1.A | monomer | 0.55 | 1×ZN; | 58.31 | ||
| Assess | ||||||
| 6x34.1.B | monomer | 0.54 | 1×ZN; | 66.93 | ||
| Assess | ||||||
| 7tdg.1.A | homo-4-mer | 0.53 | 4×ZN; 4×CA; 4×ACP; 4×POV; | 52.49 | ||
| Assess | ||||||
| 6x36.1.B | monomer | 0.51 | 66.53 | |||
| Assess | ||||||
| 8dtz.1.A | monomer | 0.51 | 1×ZN; | 68.82 | ||
| Assess | ||||||
| 5l1d.1.A | monomer | 0.51 | 63.22 | |||
| Assess | ||||||
| 6wov.1.A | monomer | 0.51 | 1×ZN; | 68.79 | ||
| Assess | ||||||
25 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 8vjk.1.A | monomer | 0.73 | 1×ZN; 1×CFF; 2×ATP; 1×CA; | 67.43 | |
| Assess | ||||||
| Isoform 2 | 7tzc.1.I | monomer | 0.71 | 1×ATP; 1×ZN; 1×CFF; | 67.58 | |
| Assess | ||||||
| Isoform 2 | 8uxf.1.A | monomer | 0.70 | 1×ZN; 2×ATP; | 69.57 | |
| Assess | ||||||
| Isoform 2 | 8dve.1.J | monomer | 0.64 | 1×CFF; 1×CA; 1×ATP; 1×ZN; | 67.58 | |
| Assess | ||||||
| Isoform 2 | 6x32.1.B | monomer | 0.58 | 1×ZN; | 66.13 | |
| Assess | ||||||
| Isoform 2 | 6x35.1.B | monomer | 0.57 | 1×ZN; | 66.32 | |
| Assess | ||||||
| Isoform 2 | 6x33.1.B | monomer | 0.57 | 1×ZN; | 66.20 | |
| Assess | ||||||
| Isoform 2 | 4uwa.1.A | homo-4-mer | 0.56 | 61.48 | ||
| Assess | ||||||
| Isoform 2 | 3j8h.1.A | monomer | 0.55 | 1×ZN; | 58.31 | |
| Assess | ||||||
| Isoform 2 | 6x34.1.B | monomer | 0.55 | 1×ZN; | 66.93 | |
| Assess | ||||||
| Isoform 2 | 7tdg.1.A | homo-4-mer | 0.53 | 4×ZN; 4×CA; 4×ACP; 4×POV; | 52.54 | |
| Assess | ||||||
| Isoform 2 | 8dtz.1.A | monomer | 0.52 | 1×ZN; | 68.79 | |
| Assess | ||||||
| Isoform 2 | 6x36.1.B | monomer | 0.51 | 66.53 | ||
| Assess | ||||||
| Isoform 2 | 5l1d.1.A | monomer | 0.51 | 63.26 | ||
| Assess | ||||||
| Isoform 2 | 6wov.1.A | monomer | 0.51 | 1×ZN; | 68.77 | |
| Assess | ||||||
| Isoform 3 | 7tzc.1.I | monomer | 0.75 | 68.55 | ||
| Assess | ||||||
| Isoform 3 | 7vmo.1.A | monomer | 0.61 | 51.28 | ||
| Assess | ||||||
| Isoform 3 | 6x35.1.B | monomer | 0.59 | 63.57 | ||
| Assess | ||||||
| Isoform 3 | 6x34.1.B | monomer | 0.57 | 63.90 | ||
| Assess | ||||||
| Isoform 3 | 4uwe.1.A | homo-4-mer | 0.56 | 61.73 | ||
| Assess | ||||||
| Isoform 3 | 3j8h.1.A | monomer | 0.56 | 56.84 | ||
| Assess | ||||||
| Isoform 3 | 7tdg.1.A | homo-4-mer | 0.54 | 49.66 | ||
| Assess | ||||||
| Isoform 3 | 6x36.1.B | monomer | 0.53 | 63.73 | ||
| Assess | ||||||
| Isoform 3 | 7umz.1.A | homo-4-mer | 0.53 | 54.54 | ||
| Assess | ||||||
| Isoform 3 | 5l1d.1.A | monomer | 0.51 | 61.28 | ||
| Assess | ||||||